|
Synonyms: OPS-2071
Compound class:
Synthetic organic
Comment: OPS-2071 is a fluoroquinolone antibacterial compound, with broad-spectrum activity against both Gram-positive and Gram-negative bacteria [2]. It is a clinical candidate being developed by Otsuka Pharmaceutical (Tokyo, Japan) as a treatment for intestinal infections, particularly those caused by Clostridioides difficile. Functionally, it is a type II DNA topoisomerase inhibitor with similar activity against DNA gyrase and DNA topoisomerase 4 [1]. The chemical structure of OPS-2071 is identical to that which was submitted to the WHO for the INN abimufloxacin (proposed INN list 135, Jul 2026).
|
|
|||||||||||||||||||||||||||||||||||